EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers. - Han, Junling; Yu, Bo; Jing, Jianan; He, Xiaoyu; Hua, Yunfen; Xu, Guotai (Cellular Oncology (2211-3428), 2025)